cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Marinus Pharmaceuticals Inc
4 own
22 watching
Current Price
$0.54
$0
(-0.18%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
91.99M
52-Week High
52-Week High
10.5
52-Week Low
52-Week Low
0.22000000
Average Volume
Average Volume
0.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization91.99M
icon52-Week High10.5
icon52-Week Low0.22000000
iconAverage Volume0.6M
iconDividend Yield--
iconP/E Ratio--
What does the Marinus Pharmaceuticals Inc do?
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone). Its U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the use of ZTALMY oral suspension CV for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) in patients two years of age and older. The Company is also developing ganaxolone for the treatment of other rare genetic epilepsies, including Tuberous Sclerosis Complex (TSC) and for the treatment of Refractory Status Epilepticus (RSE). It is developing ganaxolone in formulations for two different routes of administration: intravenous (IV) and oral to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings.
Read More
How much money does Marinus Pharmaceuticals Inc make?
News & Events about Marinus Pharmaceuticals Inc.
PR Newswire
1 year ago
Thinking about buying stock in Marinus Pharmaceuticals, Eos Energy Enterprises, Lucid Group, Archer Aviation, or Polymet Mining? Thinking about buying stock in Marinus Pharmaceuticals, Eos Energy Enterprises, Lucid Group, Archer Aviation, or Polymet Mining? PR Newswire NEW YORK, July 3, 2023 NEW...
Stock Options Channel
1 year ago
Investors considering a purchase of Marinus Pharmaceuticals Inc (MRNS) shares, but tentative about paying the going market price of 10.59/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the ...
PR Newswire
1 year ago
Thinking about buying stock in Marinus Pharmaceuticals, OPKO Health, Xponential Fitness, Plug Power, or Asetek A/S? Thinking about buying stock in Marinus Pharmaceuticals, OPKO Health, Xponential Fitness, Plug Power, or Asetek A/S? PR Newswire NEW YORK, June 28, 2023 NEW YORK, June 28, 2023...
PR Newswire
1 year ago
Thinking about buying stock in Advanced Micro Devices, Marinus Pharmaceuticals, AngloGold Ashanti, Duos Technologies, or GoldMining? Thinking about buying stock in Advanced Micro Devices, Marinus Pharmaceuticals, AngloGold Ashanti, Duos Technologies, or GoldMining? PR Newswire NEW YORK, May 4, 2023...
Business Wire
1 year ago
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to ganaxolone for the treatment of...
Frequently Asked Questions
Frequently Asked Questions
What is Marinus Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Marinus Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Marinus Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Marinus Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Marinus Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Marinus Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Marinus Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Marinus Pharmaceuticals Inc?
plus_minus_icon
What percentage is Marinus Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Marinus Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.54
$0
(-0.18%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
$103.11
$-0.78 (-0.75 %)
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$0.59
$0.01 (2.60 %)
PROQR THERAPEUTICS NV
PROQR THERAPEUTICS NV
$2.16
$-0.01 (-0.46 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$3.32
$-0.02 (-0.60 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
$103.11
$-0.78 (-0.75 %)
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$0.59
$0.01 (2.60 %)
PROQR THERAPEUTICS NV
PROQR THERAPEUTICS NV
$2.16
$-0.01 (-0.46 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$3.32
$-0.02 (-0.60 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00